Akelos Company
Akelos is a new biopharmaceutical company focused on the translation of innovative science into treatment.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
New York, New York, United States
Founded Date:
2018
Employees Number:
11-50
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Register and Claim Ownership